Advisory Services
Strategy across the entire Clinical Trial Access Continuum™
Advisory work for the organizations shaping how participants find trials, how they are supported inside them, and what happens to that impact afterward.
Schedule a ConversationSponsors & Biotech
Strategic advisory for pharmaceutical and biotech sponsors rethinking how participants find, experience, and are supported through clinical trials. Grounded in 15+ years of global clinical operations, a DIA Consortium landscape analysis, and first-of-its-kind AI-assisted research on 7,500+ informed consent forms.
Participant payment strategy
Ethical, operationally sound compensation across countries, modalities, and regulatory frameworks — designed upstream rather than renegotiated at site activation.
Clinical operations strategy
The operational decisions that determine whether participants can actually afford to take part — from site-level friction to cross-functional budget planning.
Global participant support
Country-specific operating realities built into one coherent global strategy, including the Whole-Person Participant Support™ framework.
Participant burden planning
Coming SoonHelping sponsors recognize and plan for total participant cost — time, family, financial, and access — during protocol design.
Technology Companies
Market positioning, go-to-market advisory, and thought leadership for the companies building the next generation of clinical trial infrastructure — helping them understand where their solutions fit and how to communicate value to sponsors.
AI-enabled patient matching
Advisory for ventures connecting eligible participants to the right trials, and for the sponsors evaluating and adopting them.
Digital health
Positioning digital health tools within real sponsor workflows, procurement realities, and participant experience.
Clinical technology companies
Sponsor-facing value communication for platforms operating across payments, engagement, and trial operations.
Innovative service providers
Go-to-market strategy and thought leadership development for emerging companies in a rapidly evolving market.
Strategic Partnerships
Some of the most durable progress in clinical trial access happens between organizations rather than inside them. I design and broker the partnerships that connect sponsors, nonprofits, technology companies, industry organizations, and academic collaborators around a shared objective.
Sponsor & nonprofit collaboration
Responsible, financially neutral engagement models — including subject matter expertise in onboarding and implementing the award-winning Kits4Life program.
Industry organizations & consortia
Convening and contributing to the working groups where industry consensus on participant support is actually formed.
Academic collaborations
Research partnerships that turn operational questions into evidence the industry can act on.
Partnership structure & compliance
Contracting, diligence, and IRB considerations that make cross-sector collaboration operationally feasible.
The DURING Framework
Whole-Person Participant Support™
The operating model behind the DURING stage of the continuum — a sponsor-embedded approach to the financial, logistical, and human barriers participants and their families actually face, including responsible engagement with nonprofit organizations.
Background
A squiggly line with a consistent purpose
Law. Diplomacy. Global health. Clinical operations. Patient advocacy. Every turn pointed toward the same question: how do we design systems that actually work for the people inside them?
15+
Years in global clinical research operations
40+
Countries covered in global participant payment mapping
7,500+
Informed consent forms analyzed for payment research
Ready to redesign access?
If your organization is rethinking how it connects, supports, or sustains clinical trial participants — let's talk.
Schedule a Conversation